Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Product/Service

OBIO's Health to Business Bridge Program (H2BB) is Preparing the Future Leaders of Ontario's Health Science Industry


OBIO's Health to Business Bridgetm Program (H2BB) prepares new hires for careers in Ontario's health science industry, helping companies build for the future in an innovative sector poised for growth.

As we all work to combat the impact of COVID-19, health science companies in Ontario continue to innovate. These companies are progressing and hiring new employees who are knowledgeable, adaptable, and ready to contribute.

H2BB has a proven track record of bringing early career talent up-to-speed quickly, through a combination of industry-specific training and pairing candidates with expert advisors. Already in 2020, OBIO H2BB has 35 new hires from 16 growing companies enrolled in its industry-specific training courses.

"By supporting programs like OBIO's Health to Business Bridge Program, our government is helping develop the talent that will lead our future economy," said Monte McNaughton, Minister of Labour, Training and Skills Development. "Ontario's innovative health science industry is an important part of that future and we are proud to help people prepare for good jobs and exciting, fulfilling careers."

OBIO H2BB: Preparing New Hires to Adapt and Contribute

Health science companies with new hires in H2BB recognize the value of getting new hires up to speed quickly. "Cohesys enrolled two employees in H2BB this year and both individuals are applying what they have learned through the H2BB training to their work at Cohesys," said Mike Tessier, COO and Co-Founder of Cohesys, an OBIO Member. "We are looking forward to enrolling additional employees in the near term."

Epineuron has enrolled additional new hires after the company's first H2BB participant spoke about the direct applicability of the program's training. "What we heard from Epineuron's first candidate in the H2BB program was that the training was especially relevant for someone who was new to the health science industry," said Mike Willand, Co-Founder and CTO of Epineuron, an OBIO Member.

H2BB participants point out how the design of the program helps them accumulate knowledge and skills quickly to make an impact. "The H2BB program provided a great opportunity for me to learn all the processes involved in transforming an idea into a commercial product ? which is exactly what I needed to know," said Goli Ameri, Senior R&D Engineer at COSM.

OBIO: Positioning the Health Science Industry for Success

Through H2BB and all its programs like CAAP®, HealthMINTtm and EAHNtm, OBIO is growing jobs in the health science industry and preparing the leaders of tomorrow's industry.

With renewed focus on innovative health technology as part of global economic recovery, OBIO is advancing key programs positioning Ontario to be a leader. As the health science industry responds to the COVID-19 pandemic, OBIO has responded in kind. OBIO's EAHN has issued a call for applications from companies to address COVID-19.

To find out more about how H2BB can help your company develop new hires, contact Andreea Norman at [email protected]. To find out how your company can build Ontario's health science industry with OBIO, contact Grant Burns at [email protected].

OBIO Health to Business Bridge Programtm

OBIO Health to Business Bridgetm program (H2BB) has a proven track record in bringing early career talent up-to-speed quickly and giving them a solid footing in the fundamentals of the health science industry. H2BB provides pre-screened candidates, advisors and training for all early career roles, including business, quality, regulatory and R&D, with the support of Employment Ontario.

About OBIO

OBIO®, founded in 2009, is a not-for-profit, membership-based innovation organization engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies positioning Canada as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.


These press releases may also interest you

at 16:15
First Trust Energy Income and Growth Fund (the "Fund") has declared its final common share distribution, which may not ultimately be made, as further discussed below, payable on May 2, 2024, to shareholders of record as of April 29, 2024. The...

at 16:15
First Trust Energy Infrastructure Fund (the "Fund") has declared its final common share distribution, payable on May 2, 2024, to shareholders of record as of April 29, 2024. The ex-dividend date is expected to be April 26, 2024. The per share rate...

at 15:05
University of Phoenix is pleased to share that College of Nursing faculty Sun Jones, DNP, RN, FNP-BC, who serves as the Systematic Plan for Evaluation and Curriculum Evaluator, has been selected for the 2024 Fellows of the American Association of...

at 14:45
The "Yeast - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Yeast Market to Reach $11.6 Billion by 2030 The global market for Yeast estimated at US$6.2 Billion in the year 2023, is projected to reach...

at 14:15
Natuzzi chooses the stage of two among the most relevant global furniture events, High Point Market in North Carolina, and the Design Week in Milan, to unveil the dense program of events and projects that will mark the calendar of its 65th...

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...



News published on and distributed by: